Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03450993 · ClinicalTrials.gov registry record · NA
SMART Program for Paroxysmal Atrial Fibrillation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03450993: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03450993 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03450993, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a pilot study to test the effects of the SMART-3RP (Stress Management and Resiliency Training Relaxation Response Resiliency Program) on quality of life, mental health, arrhythmia burden, and heart rate variability (HRV) in patients with paroxysmal atrial fibrillation (PAF).
Interventions
- OTHER SMART Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-02-23 |
| Est. Completion | 2019-01-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03450993
The ClinicalTrials.gov registry entry for NCT03450993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SMART Program is the first listed.
NCT03450993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03450993 about?
NCT03450993 is a clinical study titled "SMART Program for Paroxysmal Atrial Fibrillation". This is a pilot study to test the effects of the SMART-3RP (Stress Management and Resiliency Training Relaxation Response Resiliency Program) on quality of life, mental health, arrhythmia burden, and heart rate variability (HRV) in patients with paroxysmal atrial fibrillation (PAF).
What is the current status of trial NCT03450993?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-02-23. Estimated completion is 2019-01-04.
What interventions are being tested in trial NCT03450993?
The interventions under investigation include: SMART Program (OTHER).
Who is sponsoring clinical trial NCT03450993?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.